scispace - formally typeset
A

Andreas Bonz

Researcher at University of Würzburg

Publications -  26
Citations -  1100

Andreas Bonz is an academic researcher from University of Würzburg. The author has contributed to research in topics: Clopidogrel & Tirofiban. The author has an hindex of 14, co-authored 26 publications receiving 1045 citations.

Papers
More filters
Journal ArticleDOI

Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle.

TL;DR: The conclusion is that anandamide, R-methanandamide and HU-210 decrease contractile performance in human atrial muscle via CB1 receptors.
Journal ArticleDOI

effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)

TL;DR: The GP IIb/IIIa receptor antagonist tirofiban is able to decrease the incidence of troponin release significantly in this patient population and after nine months a reduction of combined death/myocardial infarction/target vessel revascularization could be observed in the tiroFiban group.
Journal ArticleDOI

Myosin Light Chain–Actin Interaction Regulates Cardiac Contractility

TL;DR: In this article, the amino-terminal domain of the essential myosin light chain (MLC-1) binds to the carboxy terminus of the actin molecule.
Journal ArticleDOI

The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats

TL;DR: The hypothesis that activation of ERalpha favorably affects cardiac hypertrophy, myocardial contractility, and gene expression in ovariectomized SHR is supported, and further studies are required to determine whether activation ERbeta mediates redundant or divergent effects.